Hopefully | KBLB Message Board Posts

Kraig Biocraft Laboratories, Inc.

  KBLB website

KBLB   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  6263 of 6415  at  9/22/2020 12:30:04 PM  by

3times


 In response to msg 6261 by  3times
view thread

Re: Hopefully

 What if there is production happening in the US but it is not Spider Silk
 
From the June 29th Release:
 

Global silk production is expected to reach USD 17 billion in 2021; the economic impact of eliminating the loss from disease is a multi-billion dollar opportunity. The Company anticipates that its development of a disease resistant silkworm could be licensed across the entire global silk industry.

“Our work to enhance the disease resistance of our silkworms complements and strengths our focus in bringing our recombinant spider silk to market,” said CEO and Founder, Kim Thompson. “We believe that success in this effort will also provide significant opportunities for growth far beyond the reach of Kraig’s in-house production capacity, with licensing applications globally.”

Once proven, the Company expects to merge these disease resistance properties within its existing lines of genetically enhanced recombinant spider silks.

----
Could there be some success in this area that would generate revenue for KBLB. Even if we are in a QP, wouldn't that show up in the 10-Q that would be out end of October. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 76
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board








Financial Market Data provided by
.
Loading...